title: Dopaminergic treatment of restless legs and rebound phenomenon.
authors.affiliation: Stanford University Sleep Disorders Center, CA 94304.
authors.forename: C
authors.initials: C
authors.lastname: Guilleminault
authors.forename: M
authors.initials: M
authors.lastname: Cetel
authors.forename: P
authors.initials: P
authors.lastname: Philip
mesh_terms: D000368:Aged; D002230:Carbidopa / Q000009:adverse effects / Q000627:therapeutic use*; D015259:Dopamine Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012148:Restless Legs Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology*
chemical_list: D015259:Dopamine Agents; D004338:Drug Combinations; C009265:carbidopa, levodopa drug combination; D007980:Levodopa; D002230:Carbidopa